STAT Plus: Coronavirus fears may slow clinical trials and delay regulatory steps
Initially, plans for the huge clinical trial were proceeding apace.
After months of groundwork, about 1,000 different sites were identified in 42 countries. And a key meeting involving trial investigators and coordinators from around the U.S. and Europe was scheduled to review protocols and compare notes. But then the coronavirus struck.
